Page last updated: 2024-10-25

nordazepam and MS (Multiple Sclerosis)

nordazepam has been researched along with MS (Multiple Sclerosis) in 1 studies

Nordazepam: An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.
nordazepam : A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety.

Research Excerpts

ExcerptRelevanceReference
"Eight patients with spasticity or rigidity were given placebo or active substance; first in loading doses for 2 days, then 5 mg every 12 h for a total of 10 days."2.66Effect of clorazepate in spasticity and rigidity: a quantitative study of reflexes and plasma concentrations. ( Dietrichson, P; Lossius, R; Lunde, PK, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lossius, R1
Dietrichson, P1
Lunde, PK1

Trials

1 trial available for nordazepam and MS (Multiple Sclerosis)

ArticleYear
Effect of clorazepate in spasticity and rigidity: a quantitative study of reflexes and plasma concentrations.
    Acta neurologica Scandinavica, 1985, Volume: 71, Issue:3

    Topics: Adult; Aged; Anti-Anxiety Agents; Brain Diseases; Clorazepate Dipotassium; Female; Humans; Kinetics;

1985